Potentially life-threatening conditions |
71(87.6) |
Severe postpartum hemorrhage |
41(50.6) |
Severe preeclampsia |
11(13.6) |
Eclampsia |
7(8.6) |
Sepsis or severe systemic infection |
19(23.4) |
Ruptured uterus |
12(14.8) |
Severe anemia |
9(11.1) |
Critical interventions |
39(48.1) |
Use of blood products (includes any blood transfusion) |
21(25.9) |
Interventional radiology (uterine artery embolization) |
0(0.0) |
Laparotomy |
10(12.3) |
Admission to Intensive Care Unit (ICU) |
13(16.0) |
Organ dysfunction / life-threatening conditions |
5(6.2) |
Cardiovascular dysfunction (shock, the sudden absence of pulse and loss of consciousness, use of continuous vasoactive drugs) |
1(1.2) |
Respiratory dysfunction(acute cyanosis, severe tachypnea (respiratory rate>40 bpm), severe bradypnea (respiratory rate<6 bpm), or intubation and ventilation not related to anesthesia) |
2(2.5) |
Renal dysfunction(oliguria non responsive to fluids or diuretics, or severe acute azotemia (creatinine 3.5mg/dL) |
1(1.2) |
Hepatic dysfunction (jaundice, or severe acute hyperbilirubinemia (bilirubin >6.0mg/dL) |
0(0.0) |
Neurological dysfunction (prolonged unconsciousness / coma (lasting >12 hours) |
0(0.0) |
Uterine dysfunction (hemorrhage or infection leading to hysterectomy) |
2(2.5) |
Coagulation/hematological dysfunction (failure to form clots, or massive transfusion of blood or red cells (5 units) or severe acute thrombocytopenia (<50,000 platelets/ml) |
0(0.0) |